This page lists 5 thalassemia major doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
Quick answer
This page lists 5 thalassemia major doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Thalassemia Major doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
About the Condition
What is Thalassemia Major?
Thalassemia major is a severe inherited blood disorder in which the body produces little or no functional haemoglobin, leading to chronic, life-threatening anaemia that typically becomes apparent within the first two years of life. Without consistent treatment, the body compensates by expanding bone marrow activity, which can cause skeletal deformities, growth failure, and organ enlargement. Over time, repeated blood transfusions — the cornerstone of conventional management — carry their own serious risks, most notably iron overload that can damage the heart, liver, and endocrine glands. Determining the best course of care requires a thorough review of a patient's medical history, genotype, transfusion burden, organ function, and the availability of a compatible donor, all evaluated by a qualified specialist team.
Individual assessmentEvery case is different
Complete evaluationUnderstand the condition first
Specialist reviewChoose the right approach
Medical assessment helps clarify severity and identify appropriate options.
Treatment options for Thalassemia Major
Care may include lifestyle changes, medical treatment, specialist review or a procedure, depending on the diagnosis, associated conditions and individual goals. The options below are associated with this condition in the GAF Healthcare directory.
A Matched Sibling Donor (MSD) Transplant is a stem cell transplant in which bone marrow or peripheral blood stem cells from an HLA-matched brother or sister are infused into a patient with Thalassemia Major after conditioning chemotherapy.
Why it may be consideredIt is currently the only established curative treatment for Thalassemia Major, replacing the patient's defective blood-forming cells with healthy donor cells. Outcomes are best when performed at a young age with a fully matched sibling and minimal prior iron overload or organ damage.
Bone Marrow Transplant (BMT) for Thalassemia Major is a curative treatment that replaces the patient's defective blood-forming stem cells with healthy stem cells from a matched donor, enabling normal hemoglobin production.
Why it may be consideredIt is typically recommended for children and young adults with Thalassemia Major who have a suitable donor and are in good clinical condition. India offers internationally accredited BMT centers with high success rates at a fraction of Western costs, making it a leading destination for thalassemia transplants.
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Many international patients consider India for thalassemia major treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
How this directory is built
Doctors are matched using the specialty, location, condition (Thalassemia Major) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Thalassemia Major in India
What is Thalassemia Major?
Thalassemia major (also called beta-thalassemia major or Cooley's anaemia) is the most severe form of beta-thalassemia, a genetic condition in which mutations in both copies of the HBB gene severely reduce or eliminate beta-globin production, impairing the formation of normal red blood cells. Affected individuals require lifelong medical intervention beginning in infancy.
What are the symptoms and health risks of Thalassemia Major?
Common features include severe pallor, persistent fatigue, poor growth, jaundice, an enlarged spleen or liver, and characteristic facial bone changes caused by expanded marrow activity; children may also experience frequent infections and delayed puberty. In patients managed with regular transfusions, symptoms of iron overload — such as cardiac arrhythmias, liver fibrosis, diabetes, and hormonal deficiencies — may emerge over years if iron chelation is inadequate. The presence of these signs warrants urgent specialist evaluation, but symptoms alone are not sufficient to establish a diagnosis or determine treatment.
How is Thalassemia Major diagnosed?
Diagnosis is confirmed through a combination of full blood count (showing severe microcytic hypochromic anaemia), haemoglobin electrophoresis or HPLC (demonstrating markedly reduced or absent HbA with elevated HbF and HbA2), and molecular genetic testing to identify the specific HBB mutations. Assessing disease severity and treatment eligibility also involves ferritin levels and MRI-based liver and cardiac iron quantification (T2* MRI), liver function tests, echocardiography, and — when transplant is being considered — HLA typing of the patient and potential donors. A complete picture of organ function and transfusion history is essential before any management plan is finalised.
How is Thalassemia Major treated?
Management strategy depends on the patient's age, clinical severity, organ function, iron burden, and whether a matched donor is available. For most patients, the standard long-term approach involves regular red cell transfusions combined with iron chelation therapy to prevent organ damage from iron accumulation. For eligible patients — particularly children with good organ function and a matched sibling donor — allogeneic bone marrow transplantation (BMT) offers the only currently established curative option and is the procedure offered within our directory; a qualified specialist team will determine whether a patient meets the criteria for transplant.
Can Thalassemia Major be treated without surgery?
Non-procedural management — primarily regular red cell transfusions every 2–4 weeks combined with daily or infusion-based iron chelation therapy (using agents such as deferoxamine, deferasirox, or deferiprone) — is the mainstay of treatment for patients who are not transplant candidates or who are awaiting transplant. This approach can sustain quality of life and prevent major organ damage for many years but does not correct the underlying genetic defect, meaning it requires lifelong continuation. Emerging therapies including luspatercept and gene therapy are available in some specialist centres and clinical trials, and a haematologist can advise on whether a patient qualifies.
When is Matched Sibling Donor Transplant considered for Thalassemia Major?
Matched Sibling Donor Transplant may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.
Which doctor treats Thalassemia Major?
Thalassemia major is primarily managed by a paediatric or adult haematologist with expertise in haemoglobinopathies, working alongside a bone marrow transplant (BMT) physician when curative treatment is being considered. Comprehensive care typically also involves an endocrinologist, cardiologist, and hepatologist to monitor and treat the complications of iron overload.
How do I choose a doctor for Thalassemia Major?
When comparing providers, look for a BMT centre with documented experience specifically in transplantation for haemoglobinopathies, clear data on transplant-related outcomes, a multidisciplinary team that includes iron-overload specialists, and a structured long-term follow-up programme covering both engraftment monitoring and endocrine or cardiac surveillance.
What documents do international patients need to share for a medical evaluation?
Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.
